Based on the importance of EGFR signaling in lung cancer, the known cooperation between EGFR and SRC proteins, and evidence of elevated SRC activity in human NSCLC, several studies have also evaluated the therapeutic effectiveness of SRC kinase inhibitors in lung cancer [57,234]. The gene discussed is SRC; the disease is lung carcinoma.